# High Dose Chemo/Radiotherapy and Hematopoietic Stem Cell Transplant for Patients With Multiple Sclerosis

> **NCT00040482** · PHASE2 · COMPLETED · sponsor: **Baylor College of Medicine** · enrollment: 10 (—)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **DRUG:** Cyclophosphamide
- **DRUG:** ATG
- **DRUG:** MESNA
- **PROCEDURE:** Radiation therapy

## Key facts

- **NCT ID:** NCT00040482
- **Lead sponsor:** Baylor College of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-04
- **Primary completion:** —
- **Final completion:** 2005-08
- **Target enrollment:** 10 (—)
- **Last updated:** 2020-01-18

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00040482

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00040482, "High Dose Chemo/Radiotherapy and Hematopoietic Stem Cell Transplant for Patients With Multiple Sclerosis". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT00040482. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*